ReGEV Bio
RNA-Based Gene Regulation for Climate-Resilient Crops
Company Overview
Snapshot
Founded in January 2022, ReGEV Bio operates with 1–10 employees. In January 2022, ReGEV Bio secured seed funding from AgChimedes Group to advance its RNA-based gene regulation technology for climate-resilient crops.
Business overview
ReGEV Bio is a biotechnology company focused on enhancing plant resilience and productivity. The company utilizes RNA interference (RNAi) technology to transiently adjust gene expression, aiming to improve crop adaptation to environmental stresses without permanent genetic modifications. This approach provides farmers and the seed industry with tools to optimize existing crop varieties in response to climate challenges, operating within the Agriculture & Food Technologies sector, specifically in sustainable farming and ag tech.
Log in to access full profile ›Company Intelligence Q&A
- What is ReGEV Bio's core technology?
- ReGEV Bio's core technology involves utilizing RNA interference (RNAi) to transiently adjust gene expression in plants, enhancing their resilience and productivity without permanent genetic modifications.
- When was ReGEV Bio founded?
- ReGEV Bio was founded in January 2022.
- Which sector does ReGEV Bio primarily operate in?
- ReGEV Bio primarily operates in the Agriculture & Food Technologies sector, with a focus on sustainable farming and ag tech.
- What is ReGEV Bio's mission regarding crop development?
- ReGEV Bio aims to provide farmers and the seed industry with tools to optimize existing crop varieties, helping them adapt to environmental stresses and climate challenges through gene regulation.